Chronic renal failure secondary to oxalate nephropathy

A preventable complication after jejunoileal bypass

Imran Hassan, Luis A. Juncos, Dawn S. Milliner, Juan M. Sarmiento, Michael G. Sarr

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Enteric hyperoxaluria is a commonly seen adverse event after the jejunoileal bypass procedure. The increased concentration of urinary oxalate predisposes bypass patients to various renal complications such as nephrolithiasis and oxalate nephropathy. If not diagnosed and appropriately treated, these complications can lead to irreversible renal damage. We describe 3 patients in whom severe renal complications developed with irreversible compromise of renal function after a jejunoileal bypass. Patients who undergo a jejunoileal bypass require lifelong follow-up with close monitoring of their renal function. Marked decline in renal function mandates prompt investigation and aggressive intervention, including reversal of the jejunoileal bypass if necessary. Chronic renal failure secondary to oxalate nephropathy is preventable and treatable but may require conversion of a jejunoileal bypass to a more current form of bypass.

Original languageEnglish (US)
Pages (from-to)758-760
Number of pages3
JournalMayo Clinic Proceedings
Volume76
Issue number7
StatePublished - 2001

Fingerprint

Jejunoileal Bypass
Oxalates
Chronic Kidney Failure
Kidney
Hyperoxaluria
Nephrolithiasis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hassan, I., Juncos, L. A., Milliner, D. S., Sarmiento, J. M., & Sarr, M. G. (2001). Chronic renal failure secondary to oxalate nephropathy: A preventable complication after jejunoileal bypass. Mayo Clinic Proceedings, 76(7), 758-760.

Chronic renal failure secondary to oxalate nephropathy : A preventable complication after jejunoileal bypass. / Hassan, Imran; Juncos, Luis A.; Milliner, Dawn S.; Sarmiento, Juan M.; Sarr, Michael G.

In: Mayo Clinic Proceedings, Vol. 76, No. 7, 2001, p. 758-760.

Research output: Contribution to journalArticle

Hassan, I, Juncos, LA, Milliner, DS, Sarmiento, JM & Sarr, MG 2001, 'Chronic renal failure secondary to oxalate nephropathy: A preventable complication after jejunoileal bypass', Mayo Clinic Proceedings, vol. 76, no. 7, pp. 758-760.
Hassan, Imran ; Juncos, Luis A. ; Milliner, Dawn S. ; Sarmiento, Juan M. ; Sarr, Michael G. / Chronic renal failure secondary to oxalate nephropathy : A preventable complication after jejunoileal bypass. In: Mayo Clinic Proceedings. 2001 ; Vol. 76, No. 7. pp. 758-760.
@article{7be82a5115d34320af0540e85a671ca2,
title = "Chronic renal failure secondary to oxalate nephropathy: A preventable complication after jejunoileal bypass",
abstract = "Enteric hyperoxaluria is a commonly seen adverse event after the jejunoileal bypass procedure. The increased concentration of urinary oxalate predisposes bypass patients to various renal complications such as nephrolithiasis and oxalate nephropathy. If not diagnosed and appropriately treated, these complications can lead to irreversible renal damage. We describe 3 patients in whom severe renal complications developed with irreversible compromise of renal function after a jejunoileal bypass. Patients who undergo a jejunoileal bypass require lifelong follow-up with close monitoring of their renal function. Marked decline in renal function mandates prompt investigation and aggressive intervention, including reversal of the jejunoileal bypass if necessary. Chronic renal failure secondary to oxalate nephropathy is preventable and treatable but may require conversion of a jejunoileal bypass to a more current form of bypass.",
author = "Imran Hassan and Juncos, {Luis A.} and Milliner, {Dawn S.} and Sarmiento, {Juan M.} and Sarr, {Michael G.}",
year = "2001",
language = "English (US)",
volume = "76",
pages = "758--760",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "7",

}

TY - JOUR

T1 - Chronic renal failure secondary to oxalate nephropathy

T2 - A preventable complication after jejunoileal bypass

AU - Hassan, Imran

AU - Juncos, Luis A.

AU - Milliner, Dawn S.

AU - Sarmiento, Juan M.

AU - Sarr, Michael G.

PY - 2001

Y1 - 2001

N2 - Enteric hyperoxaluria is a commonly seen adverse event after the jejunoileal bypass procedure. The increased concentration of urinary oxalate predisposes bypass patients to various renal complications such as nephrolithiasis and oxalate nephropathy. If not diagnosed and appropriately treated, these complications can lead to irreversible renal damage. We describe 3 patients in whom severe renal complications developed with irreversible compromise of renal function after a jejunoileal bypass. Patients who undergo a jejunoileal bypass require lifelong follow-up with close monitoring of their renal function. Marked decline in renal function mandates prompt investigation and aggressive intervention, including reversal of the jejunoileal bypass if necessary. Chronic renal failure secondary to oxalate nephropathy is preventable and treatable but may require conversion of a jejunoileal bypass to a more current form of bypass.

AB - Enteric hyperoxaluria is a commonly seen adverse event after the jejunoileal bypass procedure. The increased concentration of urinary oxalate predisposes bypass patients to various renal complications such as nephrolithiasis and oxalate nephropathy. If not diagnosed and appropriately treated, these complications can lead to irreversible renal damage. We describe 3 patients in whom severe renal complications developed with irreversible compromise of renal function after a jejunoileal bypass. Patients who undergo a jejunoileal bypass require lifelong follow-up with close monitoring of their renal function. Marked decline in renal function mandates prompt investigation and aggressive intervention, including reversal of the jejunoileal bypass if necessary. Chronic renal failure secondary to oxalate nephropathy is preventable and treatable but may require conversion of a jejunoileal bypass to a more current form of bypass.

UR - http://www.scopus.com/inward/record.url?scp=0034960824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034960824&partnerID=8YFLogxK

M3 - Article

VL - 76

SP - 758

EP - 760

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 7

ER -